BD - Earth day 2024

Next Generation FibroScan® Redefines Liver Disease Assessment Standards

Monday, February 26, 2024

In the United States, where more than 100 million people are affected by various liver diseases but only 4.5 million have been diagnosed, Echosens, a leader in liver health, introduces its latest innovation: Guided Vibration-Controlled Transient Elastography (VCTE)™ technology, exclusive to new FibroScan® systems. As liver disease rates continue to rise, the launch of this groundbreaking FibroScan® system addresses the critical need for precise, non-invasive liver assessment, catering to healthcare professionals dedicated to patient care. With one in ten individuals now at risk globally, increasing screening rates is imperative to prevent a potential surge in liver disease diagnoses.

This cutting-edge technology plays a pivotal role in combatting the rise of metabolic dysfunction-associated fatty liver disease (MAFLD) and metabolic dysfunction-associated steatohepatitis (MASH) in the United States. Leveraging Echosens' diagnostic expertise, Guided VCTE offers accurate liver stiffness measurements, a vital fibrosis marker, facilitating rapid, non-invasive evaluations across diverse patient demographics.

Patients benefit from expedited assessments, reducing anxiety and discomfort, while healthcare professionals experience improved diagnostic speed and workflow. Key features of Guided VCTE include:

  • Enhanced efficiency: Completing a full scan in just four minutes, Guided VCTE streamlines workflow in busy healthcare settings, enhancing accessibility to liver health assessments.
  • Improved guidance: New visual indicators for liver stiffness and CAP™ assist operators in swiftly identifying optimal measurement locations.
  • Simplified scanning: A refreshed user interface and the AutoScan feature simplify the process, enabling operators to capture ten valid measurements with a single click, enhancing efficiency without sacrificing quality.

This advancement represents a significant step forward in simplifying liver disease diagnosis and management, making liver assessments more accessible and seamlessly integrated into practices than ever before.




Healthcare CEO & Executive Strategy SummitHealthcare CNO SummitHealthcare CMO SummitHealthcare CFO, Financial Strategy & Revenue Cycle SummitThe Healthcare Patient Experience & Engagement Summit 2024Healthcare Innovation & Transformation Summit